National Institute

CHOP Study Finds Multiple Disparities in Completing Care After Concussions

Retrieved on: 
Tuesday, November 15, 2022
Online, Health, Injury, Polytrauma, MSCE, Philadelphia, Hospital, Rehabilitation, Pennsylvania Department of Aging, Stroke, Perelman School of Medicine at the University of Pennsylvania, Roger Hawkins (drummer), Journal, National Institute, Research, Children's Hospital, University, Population, Pediatrics, Assistant, Insurance, Minds, Education, CDC, Patient, Sex, Children's Hospital of Philadelphia, National, Health information management, Diagnosis, Head Injuries, White, Concussion, CHOP, Pharmaceutical industry, Medicine, MD

PHILADELPHIA, Nov. 15, 2022 /PRNewswire/ -- Researchers from Children's Hospital of Philadelphia (CHOP) found disparities in the completion of follow-up concussion care, particularly among pediatric patients who are publicly insured and identify as Black, suggesting barriers to care exist. The findings, recently published in the Journal of Head Trauma Rehabilitation, will help inform research funded by a newly awarded grant from the U.S. Centers for Disease Control and Prevention (CDC) aimed at addressing disparities in concussion care across socioeconomic groups.

Key Points: 
  • Concussions are a major public health issue, with nearly 2 million occurring annually in children and adolescents.
  • Yet access to care, and the ability to complete follow-up care recommendations, is not equally distributed among all concussion patients, especially those experiencing socioeconomic disadvantages.
  • This study was designed to help determine where disparities exist in concussion care, with an emphasis on determining which demographic groups may be most at-risk for health care inequities.
  • In this retrospective study, the researchers reviewed medical records of children seen in CHOP primary care clinics to determine whether pediatric concussion patients adhered to providers' follow-up recommendations and continued care until doctors cleared them to return to full activity.

The National Institute for Innovation and Technology (NIIT) and Applied Materials Establish Texas' First Apprenticeship for Semiconductor Equipment Manufacturing

Retrieved on: 
Tuesday, November 15, 2022
Adult, Growth, Texas Department of Assistive and Rehabilitative Services, Innovation, Program, Applied Materials, Austin Community College District, Population, National Institute, Solution, Ministry of Education (Malaysia), United States Department of Labor, Workforce, Industry, View, Department, K-12, AMAT, Nasdaq, ACC, Education, Multimedia, Federation, CEO, Semiconductor, Equifax Workforce Solutions, U.S. Department of Defense Strategy for Operating in Cyberspace, Assembler, Engineering, Dean (education), Unemployment, Manufacturing, NIIT, Management, Medicine, Creative industries, Technology, Labour, Nanotechnology

HANOVER, Md., Nov. 15, 2022 /PRNewswire/ -- Today, the National Institute for Innovation and Technology (NIIT), the leader in developing the nation's semiconductor talent pipeline, and Applied Materials, Inc. ("Applied"), the world's largest semiconductor equipment group, announced an agreement to establish a Registered Apprenticeship Program designed specifically to strengthen the company's technician and assembler workforce.

Key Points: 
  • "Applied Materials is excited to launch this key program at our Austin manufacturing site," said David Immenhauser, Vice President of Manufacturing at Applied Materials.
  • The Applied initiative is part of NIIT's "Growing Apprenticeships in Nanotechnology and Semiconductors" (GAINS) program, designed specifically to meet the needs of the semiconductor industry.
  • Applied Materials provides foundational technology for the semiconductor industry, supporting chip production facilities around the world.
  • We are excited to be supporting Applied Materials, a technology leader and the largest provider of equipment to semiconductor fabs around the world."

Gale Launches New ChiltonLibrary Platform to Improve User Experience and Accessibility

Retrieved on: 
Tuesday, November 15, 2022
Database, VIN, Technology, Automotive Service Excellence, Heat, National Institute, C-SPAN Video Library, Library, Maintenance, Knowledge, Student, National Highway Traffic Safety Administration, Amazon Web Services, AWS, NHTSA, Software, Workforce, Video, K-12, Education, Learning, Automotive industry, Labour, ASE, OEM, Air conditioning, Language, Publishing, Computer data storage, Online shopping, Video game console, Book

FARMINGTON HILLS, Mich., Nov. 15, 2022 /PRNewswire/ -- Car care guidance just got better for automotive DIYers, car enthusiasts and career and technical education students. Gale, part of Cengage Group, has migrated ChiltonLibrary, the most trusted digital resource for automotive repair and maintenance information, to a new cloud-based platform along with an array of new features and enhancements to improve user experience and accessibility. With streamlined navigation in a more user-friendly environment, users can more easily access and find the information they need to safely service their vehicle and prepare for the upcoming winter months.

Key Points: 
  • Gale , part of Cengage Group, has migrated ChiltonLibrary , the most trusted digital resource for automotive repair and maintenance information, to a new cloud-based platform along with an array of new features and enhancements to improve user experience and accessibility.
  • "The new ChiltonLibrary platform demonstrates our commitment to providing the best user experience possible," said Shawn Clark, senior vice president of Gale's domestic learning business.
  • "Automotive DIYers, enthusiasts and professionals consider ChiltonLibrary to be a top car care resource.
  • These enhancements build upon the previous key features that have long made ChiltonLibrary the gold standard for auto repair and maintenance information."

ISEA Honors Dr. Anthony Fauci with Distinguished Service Award for Dedication to Public Safety

Retrieved on: 
Tuesday, November 15, 2022
Laboratory, National Institute, ISEA, International Safety Equipment Association, NIAID, Infection, The Ritz-Carlton Hotel Company, Safety, Industry, School, Farm, HIV, Personal protective equipment, Association, Patient, COVID-19, CEO, Hospital, PPE, National, Disease, Surge arrester, Public health, Pharmaceutical industry

ARLINGTON, Va., Nov. 15, 2022 /PRNewswire-PRWeb/ -- The International Safety Equipment Association (ISEA) bestowed its Robert G. Hurley Distinguished Service Award on Dr. Anthony Fauci, Director of the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). The award was presented at ISEA's awards dinner on Monday, November 14, 2022, as part of the ISEA Annual Meeting at the Ritz Carlton Pentagon City, in Arlington, Virginia.

Key Points: 
  • ARLINGTON, Va., Nov.15, 2022 /PRNewswire-PRWeb/ -- The International Safety Equipment Association (ISEA) bestowed its Robert G. Hurley Distinguished Service Award on Dr. Anthony Fauci, Director of the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID).
  • "We present the Robert G. Hurley Distinguished Service Award annually to a person who, through a specific action or through a focused career, has made a significant impact in the safety and health field," said Cam Mackey, ISEA President and CEO.
  • "This year, ISEA is not only recognizing Dr. Fauci's decades-long public service that began in 1984, but also his dedication to informing the public about ways to keep safe from disease and other public health risks."
  • Headquartered in Arlington, Virginia, the International Safety Equipment Association ( ISEA ) is the trade association in the U.S. for personal protective equipment and technologies.

Microvi Awarded Over $1.1 Million to Scale its New Technology that Eliminates a Cancer-causing Chemical in Water

Retrieved on: 
Tuesday, November 15, 2022
Linda, Chromium, Drinking water, Cancer, Technology, Health, Working group, National Institute, Maintenance, Biology, Water, Biofuel, National Institute for Health and Care Excellence, Industry, Biophysical environment, San Francisco Bay Area, MNE, Water quality, Principal, CEO, NIH, Review, Oil, Renewable energy

Chromium in drinking water threatens the health of millions of people due to its link to cancers and reproductive effects.

Key Points: 
  • Chromium in drinking water threatens the health of millions of people due to its link to cancers and reproductive effects.
  • Chromium pollution is a widespread issue that affects Americans across all 50 states, according to the Environmental Working Group.
  • To address this challenge, the current Federal standard for total chromium in drinking water (100 parts per billion (ppb)) is under review.
  • Microvi developed a novel approach for chromium elimination based on its MicroNiche Engineering (MNE) platform technology.

CraniUS Appoints World Leading Neurosurgeon to Join Board of Directors

Retrieved on: 
Tuesday, November 15, 2022
Neuro, Neurological disorder, Harvey, Criticism of the Food and Drug Administration, Technology, Carmustine, Board, National Institute, Knowledge, Traffic barrier, Foundation for the National Institutes of Health, FDA, Medicine, Center, Time, Board of directors, Patient, CMS, CEO, NIH, CED, Brain, Johns Hopkins Hospital, Food, Medical device, Medical imaging, MD, Neurotechnology, Neurosurgery

BALTIMORE, Nov. 15, 2022 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and treatments for patients with chronic brain disease, announced today the appointment of Henry Brem, MD to its accomplished Board of Directors.

Key Points: 
  • Dr. Henry Brem joins CraniUS Board of Directors in further enhancing its mission to facilitate chronic and direct medicine delivery for treating brain disease.
  • Over the last several decades, Dr. Brem has built one of the largest and most prestigious brain tumor centers in the world.
  • With this, I cannot imagine a more ideal board member to help navigate CraniUS' path forward."
  • "I am absolutely thrilled to be joining the CraniUS Board of Directors.

Dental Anesthesia Market to be Worth $2.81 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Tuesday, November 15, 2022
SAN, Growth, Revenue, Pain, General officer, Dentist, Population, National Institute, Local, Awareness, Anesthetic, Dentistry, CAGR, Ageing, Radioactive decay, CDC, Patient, COVID-19, USD, Lidocaine, Mouth, Brain, Hospital, Tooth decay, Prevalence

Key Industry Insights & Findings from the report:

Key Points: 
  • Key Industry Insights & Findings from the report:
    The local segment dominated the dental anesthesia market with a market share of 52.9% in 2022.
  • Read 100 page full market research report, " Dental Anesthesia Market Size, Share & Trends Analysis Report By Type (Local, General, Sedation), By End Use (Hospitals, Dental Clinics, Others), By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • The rising demand for dental check-ups and the increased prevalence of dental problems are two factors that are primarily driving the growth of the dental anesthesia market.
  • Grand View Research has segmented the dental anesthesia market based on type, end-use, and region:
    Dental AnesthesiaMarket - Type Outlook (Revenue, USD Million, 2018 - 2030)

Innovative Online Fitness Program "Vivo" Awarded NIH Grant for Prediabetes Study

Retrieved on: 
Monday, November 14, 2022
Quality of life, Science, Program, Prediabetes, Techstars, National Institute, National Institute on Aging, Duke University School of Medicine, Research, Partnership, LDN, Muscle, RDN, Melinda Gates, Patient, Duke University, CEO, NIH, SBIR, National, Ageing, Pharmaceutical industry, Medicine

ATLANTA, Nov. 14, 2022 /PRNewswire/ -- Vivo ( teamvivo.com ) a unique virtual, live and interactive fitness program for people 55+, has been awarded a $2.3 million grant from the National Institutes of Health (NIH) to study how its science-based training strategy and personalized online small-group format can improve muscle strength, blood sugar levels and adherence to a fitness program among older adults with prediabetes.

Key Points: 
  • ATLANTA, Nov. 14, 2022 /PRNewswire/ -- Vivo ( teamvivo.com ) a unique virtual, live and interactive fitness program for people 55+, has been awarded a $2.3 million grant from the National Institutes of Health (NIH) to study how its science-based training strategy and personalized online small-group format can improve muscle strength, blood sugar levels and adherence to a fitness program among older adults with prediabetes.
  • The study is being conducted by Vivo and academic research partner Duke University.
  • The award was granted under the NIH's Fast-Track Small Business Innovative Research (SBIR)
    Program through the National Institute on Aging.
  • Vivo is a graduate of the Techstars Future of Longevity Accelerator, in partnership with Pivotal Ventures, a Melinda French Gates company.

MediPharm Labs Reports Third Quarter Results

Retrieved on: 
Monday, November 14, 2022
Automation, Growth, TSX, Medicine, Dronabinol, Stock, EBITDA, Abbreviated New Drug Application, Dementia, Intention, National Institute, National Institute on Aging, Partnership, Leadership, United Kingdom, University, THC, Efficiency, FDA, Sale, Company, GMP, Research, Ontario Court of Justice, Cannabinoid, API, CFO, Patient, CBD, Agitation, Completeness, CEO, AUD, Justice, FSE, Keck School of Medicine of USC, US Foods, Food, Ageing, OTCQX, Fine chemical, Pharmaceutical industry, Renewable energy, Brazilian Health Regulatory Agency, Q2, Q3

TORONTO, Nov. 14, 2022 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended September 30, 2022.

Key Points: 
  • TORONTO, Nov. 14, 2022 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended September 30, 2022.
  • Subsequent to the quarter, the Company completed the previously announced sale of MediPharm Labs Australia Pty Ltd for AUD$7.25M.
  • In Q3 2022 MediPharm held number 2 share nationally in this subcategory, according to Hyfire point of sale data.
  • Greg Hunter, CFO, MediPharm Labs added, "In Q3 MediPharm continued to make progress improving both revenue and adjusted EBITDA on a sequential and year over year basis as we continue our path towards profitability.

Investor Summit Group Announces Soligenix, Inc. To Present at Q4 Conference

Retrieved on: 
Friday, November 11, 2022
Defense Threat Reduction Agency, Complimentary, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Biomedical Advanced Research and Development Authority, T-cell lymphoma, Infection, Company, IDR, NASDAQ, Food, NIAID, Cancer, Technology, Public health, Senior, CTCL, Inflammation, Specialization, National Institute of Allergy and Infectious Diseases, National Institute, Psoriasis, Seventh Avenue, 1X1=1 (To Be One), COVID-19, BARDA, BDP, DTRA, Sheraton New York Times Square Hotel, Protalix BioTherapeutics, Development, Pharmaceutical industry, Security (finance), Princeton University

Princeton, New Jersey--(Newsfile Corp. - November 11, 2022) - Investor Summit Group, today announced that Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company) will attend the Q4 Investor Summit live in NYC at the Sheraton Times Square.

Key Points: 
  • Princeton, New Jersey--(Newsfile Corp. - November 11, 2022) - Investor Summit Group, today announced that Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company) will attend the Q4 Investor Summit live in NYC at the Sheraton Times Square.
  • Jonathan Guarino, the Company's Senior Vice President and Chief Financial Officer, will be presenting a Company update and attend 1x1 meetings.
  • The presentation will be webcast and an archived recording will be made available in the Investor events section of the Soligenix website .
  • The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known as ThermoVax.